Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.7%

6 terminated/withdrawn out of 29 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

5 recruiting1 with results5 withdrawn

Enrollment Performance

Analytics

N/A
15(78.9%)
Phase 2
3(15.8%)
Phase 1
1(5.3%)
19Total
N/A(15)
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials
NCT07575763Not ApplicableNot Yet Recruiting

CT-Guided vs Conventional DLT Sizing in Thoracic Surgery

Role: lead

NCT07553260Not ApplicableNot Yet Recruiting

Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis

Role: lead

NCT04071704Completed

Assessing Health-related Quality of Life in Sarcoma Patients

Role: collaborator

NCT07371403Not ApplicableRecruiting

MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia

Role: lead

NCT07274904Not ApplicableNot Yet Recruiting

Virtual Versus In-Person Approaches

Role: collaborator

NCT07271121Phase 2Recruiting

Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL

Role: lead

NCT05592938Not ApplicableRecruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Role: collaborator

NCT05014191Completed

Treatment Positioning in Vulvar Cancer Radiation Therapy

Role: lead

NCT04066868Not ApplicableCompleted

Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-Rater Reliability of Common Terminology Criteria for Adverse Event Ratings

Role: collaborator

NCT04920656Completed

Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

Role: lead

NCT04920513Completed

Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.

Role: lead

NCT04203524Not ApplicableTerminated

Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis

Role: lead

NCT06689358Not ApplicableCompleted

Thoracic Paravertebral Block for Postoperative Pain Management After VATS

Role: lead

NCT05653063Recruiting

ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer

Role: collaborator

NCT05836337Not ApplicableCompleted

Clinical Trial Evaluating the Effectiveness of a Tattoo Compared to a Clip Applied to Axillary Lymph Nodes in Breast Cancer Patients Who Undergo SLNBx

Role: lead

NCT04731051Phase 1Withdrawn

The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients

Role: lead

NCT03742596Phase 2Withdrawn

Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients

Role: lead

NCT04018235Completed

Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer

Role: collaborator

NCT03707860Withdrawn

Radiation Oncology Mobile Application

Role: lead

NCT04374903Not ApplicableWithdrawn

Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients

Role: lead